申请人:Pfizer Inc.
公开号:US05607960A1
公开(公告)日:1997-03-04
The present invention relates to 3,5-disubstituted indole compounds which are selective agonists which act on 5-hdroxytryptamine receptors useful in the treatment of migraine.
本发明涉及3,5-二取代吲哚化合物,它们是选择性激动剂,作用于对治疗偏头痛有用的5-羟色胺受体。